A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO2) by Germuska, Michael et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/130430/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Germuska, Michael, Chandler, Hannah, Okell, Thomas, Fasano, Fabrizio, Tomassini, Valentina,
Murphy, Kevin and Wise, Richard 2020. A frequency-domain machine learning method for dual-
calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of
oxygen consumption (CMRO2). Frontiers in Artificial Intelligence 10.3389/frai.2020.00012 file 
Publishers page: https://www.frontiersin.org/articles/10.3389/frai....
<https://www.frontiersin.org/articles/10.3389/frai.2020.00012/abstract>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
  
A frequency-domain machine learning method for dual-calibrated 
fMRI mapping of oxygen extraction fraction (OEF) and cerebral 
metabolic rate of oxygen consumption (CMRO2) 
Michael Germuska1, Hannah Chandler1, Thomas Okell2, Fabrizio Fasano3, Valentina 1 
Tomassini1,4,5, Kevin Murphy1, Richard Wise1,6. 2 
1 CUBRIC, Department of Psychology, Cardiff University, Cardiff, United Kingdom 3 
2 Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical 4 
Neurosciences, University of Oxford, United Kingdom 5 
3
 Siemens Healthcare Ltd, Frimley, Camberley, UK. 6 
4 Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of 7 
Medicine, Cardiff, United Kingdom 8 
5
 Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio University" of Chieti-9 
Pescara, 66100, Chieti, Italy 10 
6
 Institute for Advanced Biomedical Technologies, "G. D'Annunzio University" of Chieti-Pescara, 11 
66100, Chieti, Italy 12 
* Correspondence:  13 
Michael Germuska 14 
germuskam@cardiff.ac.uk 15 
Keywords: magnetic resonance imaging, metabolism, oxygen extraction fraction, CMRO2, 16 
OEF, BOLD, artificial neural networks, machine learning, calibrated-fMRI. 17 
Abstract 18 
Magnetic resonance imaging (MRI) offers the possibility to non-invasively map the brain’s metabolic 19 
oxygen consumption (CMRO2), which is essential for understanding and monitoring neural function 20 
in both health and disease. However, in depth study of oxygen metabolism with MRI has so far been 21 
hindered by the lack of robust methods. One MRI method of mapping CMRO2 is based on the 22 
simultaneous acquisition of cerebral blood flow (CBF) and blood oxygen level dependent (BOLD) 23 
weighted images during respiratory modulation of both oxygen and carbon dioxide. Although this 24 
dual-calibrated methodology has shown promise in the research setting, current analysis methods are 25 
unstable in the presence of noise and/or are computationally demanding. In this paper, we present a 26 
machine learning implementation for the multi-parametric assessment of dual-calibrated fMRI data. 27 
The proposed method aims to address the issues of stability, accuracy, and computational overhead, 28 
removing significant barriers to the investigation of oxygen metabolism with MRI. The method 29 
utilizes a time-frequency transformation of the acquired perfusion and BOLD-weighted data, from 30 
which appropriate feature vectors are selected for training of machine learning regressors. The 31 
implemented machine learning methods are chosen for their robustness to noise and their ability to 32 
map complex non-linear relationships (such as those that exist between BOLD signal weighting and 33 
blood oxygenation). An extremely randomized trees (ET) regressor is used to estimate resting blood 34 
flow and a multi-layer perceptron (MLP) is used to estimate CMRO2 and the oxygen extraction 35 
fraction (OEF). Synthetic data with additive noise are used to train the regressors, with data 36 
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simulated to cover a wide range of physiologically plausible parameters. The performance of the 37 
implemented analysis method is compared to published methods both in simulation and with in-vivo 38 
data (n=30). The proposed method is demonstrated to significantly reduce computation time, error, 39 
and proportional bias in both CMRO2 and OEF estimates. The introduction of the proposed analysis 40 
pipeline has the potential to not only increase the detectability of metabolic difference between 41 
groups of subjects, but may also allow for single subject examinations within a clinical context.  42 
 43 
1 Introduction 44 
Under normal conditions the brain’s energy needs are met via a continuous supply of oxygen and 45 
glucose for the local production of ATP via aerobic metabolism (Verweij et al., 2007). Any 46 
disruption of the supply of oxygen to the brain tissue can have significant consequences (Safar, 47 
1988), and impaired cerebral oxygen metabolism is associated with a wide variety of neurological 48 
conditions (Frackowiak et al., 1988; Ishii et al., 1996; Miles and Williams, 2008). Therefore, 49 
monitoring and mapping the brain’s consumption of oxygen is vital for understanding the diseases 50 
and mechanisms by which the metabolic consumption of oxygen may be affected. The cerebral 51 
metabolic rate of oxygen consumption (CMRO2) has traditionally been measured with positron 52 
emission tomography (Frackowiak et al., 1980). However, this method has some substantial 53 
limitations including the use of ionizing radiation and the need for local production of 15-oxygen 54 
labeled tracers. Due to these limitations there is great interest in developing alternative, non-invasive, 55 
methods of mapping CMRO2. One promising technique of non-invasively mapping CMRO2 is the 56 
so-called dual-calibrated fMRI (dc-fMRI) method (Bulte et al., 2012; Gauthier et al., 2012). This 57 
method is finding growing adoption in the research setting, and has already been applied in 58 
Alzheimer’s disease (Lajoie et al., 2017), carotid artery occlusion (De Vis et al., 2015), and studies of 59 
pharmacological modulation (Merola et al., 2017). For a review of the method and details on the its 60 
practical application please see (Germuska and Wise, 2019). Despite the promise shown by this 61 
technique, the reported between-session repeatability is relatively low (Merola et al., 2018) and 62 
improvements in the data acquisition and/or analysis are required if individualized assessment is to 63 
be made possible.  64 
One of the key difficulties in analyzing dual-calibrated fMRI data is noise propagation through the 65 
analysis pipeline, which leads to unstable parameter estimates. We have previously presented 66 
regularized non-linear least squares fitting approaches that utilize prior physiological knowledge to 67 
produce more robust parameter estimates (Germuska et al., 2019; Germuska et al., 2016). Even 68 
though such regularization reduces the mean square error it does so by trading off a reduction in 69 
variance with an increase in bias. An alternative approach to reduce the prediction error is the use of 70 
noise insensitive machine learning regression methods. Decision tree based regression methods, for 71 
example random forest (Breiman, 2001) and extremely randomized trees (Geurts et al., 2006), are 72 
robust to both output (Breiman, 2001; Geurts et al., 2006) and input noise (Yue et al., 2018) and are 73 
able to capture non-linear relationships between input features and target parameters. This noise 74 
immunity is likely due to the randomization included in the choices of features at splitting nodes 75 
(random forest) and cut-points (extremely randomized trees), which improve the generalizability of 76 
the regressors. For non-linear mappings with a high degree of complexity artificial neural networks 77 
such as the multi-layer perceptron (MLP), a feedforward network with multiple hidden layers, offer a 78 
machine learning method that is inherently robust to noise (Bernier et al., 1999). In this paper we 79 
present an analysis pipeline comprised of an extremely randomized trees regressor and a MLP, 80 
cascaded to infer resting CBF and CMRO2 from dual-calibrated fMRI data. A frequency-domain 81 
   CMRO2 frequency-domain machine learning 
 
3 
representation of simulated MRI data with the additive noise is used to train each of the regressors. 82 
Simulated data has the advantage over in-vivo data in this application as it allows a balanced dataset 83 
to be generated that covers a broad range of physiological variation. Such a dataset is essential to 84 
avoid bias in parameter estimation and to provide generalizability across groups and diseases. A 85 
frequency-domain representation is chosen as it allows for convenient dimensionality reduction, with 86 
most of the information of interest encoded at low temporal frequencies, and takes advantage of the 87 
superior ability of artificial neural networks to learn discriminative features from frequency-domain 88 
representation of a signal compared to a time-domain representation (Hertel et al., 2016). The 89 
performance of the proposed machine learning (ML) implementation is compared to an existing 90 
regularized non-linear least squares (rNLS) method (Germuska et al., 2019) both in simulation and in 91 
data acquired from a cohort of 30 healthy volunteers. We hypothesized that the machine learning 92 
approach would be able to achieve comparable or reduced prediction error with significantly reduced 93 
bias and computational overhead. 94 
2 MRI Data Acquisition 95 
Thirty healthy volunteers (16 males, mean age 32.53 ± 6.06 years) were recruited to the study. The 96 
local ethics committee approved the study and written informed consent was obtained from each 97 
participant. Blood samples were drawn via a finger prick prior to scanning and were analyzed with 98 
the HemoCue Hb 301 System (HemoCue, Ängelholm, Sweden) to calculate the systemic [Hb] value 99 
for each participant. All data was acquired using a Siemens MAGNETOM Prisma (Siemens 100 
Healthcare GmbH, Erlangen) 3T clinical scanner with a 32-channel receiver head coil (Siemens 101 
Healthcare GmbH, Erlangen). The acquisition protocol was as previously described (Germuska et al., 102 
2019). Briefly, an 18-minute dual-excitation pseudo-continuous arterial spin labeling (pCASL) and 103 
BOLD-weighted acquisition was acquired during modulation of inspired oxygen and carbon dioxide. 104 
Gas modulation was performed according to a protocol previously proposed by our lab (Germuska et 105 
al., 2016), and end-tidal monitoring was performed throughout the acquisition from the volunteer’s 106 
facemask using a rapidly responding gas analyzer (PowerLab®, ADInstruments, Sydney, Australia). 107 
The prototype pCASL sequence (Germuska et al., 2019) parameters were as follows: post-labeling 108 
delay and label duration 1.5 seconds, EPI readout with GRAPPA acceleration (factor = 3), TE1 = 109 
10ms, TE2 = 30ms, TR = 4.4 seconds, 3.4 x 3.4mm in-plane resolution, and 15 (7mm) slices with 110 
20% slice gap. 111 
3 Synthetic MRI Data Generation 112 
Synthetic data was simulated to match the 18-minute in-vivo acquisition protocol using standard 113 
physiological models for the change in BOLD signal (Bulte et al., 2012; Gauthier and Hoge, 2013; 114 
Wise et al., 2013), as summarized by equation 1.  115 
∆ܤܱܮܦܤܱܮܦ0 = M{  
  ͳ − (ܥܤܨܥܤܨ0)ఈ ൮ ͳ − ܥܱܽ2 − ܥܯܴܱ2 ܥܤܨ⁄�[�ܾ]ͳ − ܥܱܽ2,0 − ܥܯܴܱ2,0 ܥܤܨ0⁄�[�ܾ] )
ఉ
}  
                     ሺͳሻ 116 
Where, ∆ܤܱܮܦ/ܤܱܮܦ0 is the fractional change in BOLD signal due to a change in arterial oxygen 117 
content (CaO2) or CBF due to either a hyperoxic or hypercapnic respiratory stimulus. M is a lumped 118 
parameter that is equal to ܭ ∙ (ሺͳ − ܵ�ܱ2ሻ ∙ [�ܾ]൯ఉ. Where K is a scaling factor dependent on the 119 
field strength, resting venous blood volume, tissue structure, and water diffusion effects in the 120 
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extravascular space. [Hb] is the blood hemoglobin concentration and SvO2 is the venous oxygen 121 
saturation. φ is the oxygen binding capacity for Hb (1.34 ml/g), α is the Grubb exponent that couples 122 
blood volume and blood flow changes, and β is a field strength dependent constant that summarizes 123 
the non-linear effects associated with the tissue structure and water diffusion effects. The values of α 124 
and β were fixed to the optimized values (0.06 and 1) found by (Merola et al., 2016), which minimize 125 
the error in OEF estimates over a range of vascular physiology. The subscript 0 represents the 126 
baseline or resting state. The hyperoxic and hypercapnic stimuli are assumed to be iso-metabolic, so 127 
CMRO2 = CMRO2,0.  128 
The arterial spin labeling signal was modeled according to the simplified pCASL kinetic model 129 
(Alsop et al., 2015), and physiological constraints on baseline parameters were applied according to a 130 
simple model of oxygen exchange (Gjedde, 2002; Hayashi et al., 2003), equation 2.  131 
ܥܯܴܱ2,0 = D [ 5ܲ0√ ʹܱܧܨ0 − ͳℎ − ௠ܲ�௡�2]                   ሺʹሻ 132 
Where D is the effective oxygen diffusivity of the capillary network and can be expressed as a 133 
product of the effective oxygen permeability and the capillary blood volume, ܦ = � ∙ ܥܤ����.  P50 is 134 
the blood oxygen tension at which hemoglobin is 50% saturated (26 mmHg), h is the Hill coefficient 135 
(2.8) and ௠ܲ�௡�2 is the minimum oxygen tension at the mitochondria (which is thought to be 136 
negligible in healthy tissue (Gjedde, 2002)). In the modeling we assume a fixed value for κ of 3 137 
μmol/mmHg/ml/min, corresponding to a typical diffusivity of 3 (Mintun et al., 2001) to 4 138 
μmol/100g/mmHg/min (Vafaee and Gjedde, 2000) for CBVcap = 1 to 1.33 ml/100g. The 139 
physiological parameter space encompasses a wide range of plausible physiology including both 140 
healthy and dysfunctional brain tissue, and is summarized in Table 1. A summary of MRI 141 
abbreviations and all model parameters used in the simulations is given in table 2. 142 
The partial pressure of arterial oxygen (PaO2) and change in carbon dioxide (ΔPaCO2) were modeled 143 
to match the range of end-tidal recordings acquired from healthy volunteers. The baseline PaO2 had a 144 
range of 90-120 mmHg, ΔPaO2 was 200 to 300 mmHg, and ΔPaCO2 was set to 8-12 mmHg. 145 
Rectangular stimulus blocks were convolved with a gamma density function with shape parameter 146 
0.5-2.5 to account for the variation in biological rise and fall times of the hyperoxic and hypercapnic 147 
stimuli. Drift in ΔPaCO2, which was observed in some subjects, was included by adding a bandpass 148 
filtered noise signal (4th order IIR filter, lowcut/highcut = 0.005/0.05 of the Nyquist frequency). 149 
Change in the arterial blood longitudinal relaxation rate due to dissolved oxygen was included in 150 
pCASL calculations as per (Germuska et al., 2019). Noise (BOLD tSNR = 90, pCASL tSNR = 3 for 151 
CBF = 60 ml/100g/min) was added to simulated BOLD and pCASL time series. The pCASL noise 152 
was bandpass filtered (4th order IIR filter, lowcut/highcut = 0.05/0.8 of the Nyquist frequency) and 153 
the BOLD noise was lowpass filtered (1st order IIR filter, highcut = 0.5 of the Nyquist frequency) to 154 
match the noise characteristics of the in-vivo data. In addition, the BOLD timeseries data was 155 
highpass filtered with a 320 second cut-off using the filter implementation in FSL (Jenkinson et al., 156 
2012), which is routinely used for de-trending fMRI data. Figure 1 shows 50 randomly generated 157 
pCASL and BOLD timeseries overlaid with the temporal mean to demonstrate the typical output of 158 
the simulations. Please note that the pCASL timeseries are divided by the equilibrium magnetization 159 
of arterial blood (M0blood), and the baseline signal has been set to zero for display purposes. 160 
4 Methods 161 
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A schematic diagram describing the analysis/training pipeline is shown in figure 2. ASL and BOLD 162 
timeseries data, either simulated (as described in section 3) or in-vivo data, are Fourier transformed 163 
into magnitude and phase data. This frequency domain data is then truncated after the first 15 data 164 
points (low pass filtered) and combined with physiological recordings and sequence parameters to 165 
create a feature vector for model training/prediction (if in-vivo data is being analyzed). Parameter 166 
estimation is carried out in a two-stage process; first the resting blood flow (CBF0) is estimated, and 167 
then rate of oxygen consumption.  168 
Truncation of the frequency domain data removes high-frequency content that is unrelated to either 169 
the hyperoxic or hypercapnic respiratory modulations and thus removes noise from the training data. 170 
The resting blood flow is estimated separately from the rate of oxygen consumption to reduce the 171 
complexity of the required mapping between the MRI data and the target parameters. Additionally, 172 
the use of extremely randomized trees (ET) regression rather than an artificial neural network at this 173 
stage in the pipeline takes full advantage of the noise immunity of decision tree based methods (Yue 174 
et al., 2018) and reduces the potential of overfitting. The inclusion of the post-label delay in the 175 
feature vector is necessary to incorporate an implicit slice timing correction for CBF0 calculation, 176 
while the blood oxygenation parameters ([Hb], ΔPaO2, SaO2,0, CaO2,0 ) are included here due to the 177 
influence of dissolved oxygen on the longitudinal relaxation rate of arterial blood. In total each 178 
feature vector that is input into the ET regressor consists of 65 entries.  179 
The result of the ET regression is then incorporated into the feature vector (now 66 entries) and input 180 
into an ensemble of MLPs to predict CMRO2,0 / CaO2,0, from which CMRO2,0 and OEF0 can be 181 
calculated (CMRO2 / CaO2 = OEF x CBF via the Fick principle). The blood oxygenation parameters 182 
in this case not only inform on the relaxation rate of arterial blood, but also link the CBF and BOLD 183 
signal changes to the underlying metabolic parameters as described by equation 1. In practice each 184 
MLP in the ensemble is trained individually, with the average of their predictions being used for 185 
inference when deployed for the analysis of in-vivo data.  186 
The ET regressor and MLP were implemented in Scikit learn (Pedregosa et al., 2011). The extremely 187 
randomized trees regressor was trained with the following options, number of estimators = 50, 188 
bootstrap = True, and out-of-bag samples were used to estimate the R2 on unseen data. A total of 189 
50,000 simulations were used for training. The MLP network has two-hidden layers and 50 nodes in 190 
each layer. The activation function for each node was chosen to be a rectified linear unit (ReLU). The 191 
ADAM solver was used for training with 1x106 simulated feature vectors and 10% of the data were 192 
used for early stopping. Data simulation and training was repeated 40 times to create an ensemble of 193 
MLP networks to further reduce the uncertainty in parameter estimates (Sollich and Krogh, 1996). 194 
The validation score for the extremely randomized trees regressor for predicting resting cerebral 195 
blood flow was 0.997, slightly greater than the results obtained for a random forest implementation 196 
(0.961). The validation score for the MLP estimation of CMRO2,0 / CaO2,0 were 0.923 ± 0.002. 197 
Training of the MLP network was also undertaken while eliminating key elements of the simulation 198 
or feature vectors to see how this affected the performance of the MLP. When BOLD data was 199 
excluded from the feature vector the validation score dropped to 0.577. Excluding the CO2 and O2 200 
stimuli (but including the BOLD data) reduced the validation scores to 0.63 and 0.71 respectively.  201 
A further 5,000 simulated datasets (with OEF restricted to 0.15 to 0.65, all other parameters as in 202 
table 1) were constructed to compare the performance of the proposed machine learning 203 
implementation with a previously implemented regularized non-linear least squares fitting method 204 
(Germuska et al., 2019). Each method was compared to the simulated data using a robust regression 205 
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method (bisquare) in terms of the RMS error and proportional bias. A bisquare cost function was 206 
used for the regression to reduce the influence of outliers and allow a robust estimate of the 207 
proportional bias. The rNLS fitting was implemented with regularization applied to the resting OEF 208 
and the effective oxygen diffusivity (D), as previously described. The relative weighting between 209 
OEF and diffusivity regularization was maintained constant, as per the optimization in (Germuska et 210 
al., 2019). However, the total weighting was varied to assess the impact on OEF and CMRO2 error 211 
and proportional bias (slope of the simulated parameter values plotted against the parameter 212 
estimates). 213 
5 Results 214 
5.1 Simulations 215 
Analysis of the simulated data demonstrated a substantial reduction in the RMS error of machine 216 
learning OEF estimates compared to rNLS estimates. The bisquare RMS error was 0.047 when using 217 
the mean prediction from the 40 MLP networks, and 0.055 for a randomly chosen MLP network. The 218 
rNLS approach produced a minimum bisquare RMS error of 0.094. The ML approach displayed 219 
negligible proportional bias in OEF estimates (slope of true vs. estimated values  = 0.982), whereas 220 
rNLS estimates had variable levels of bias depending on the level of regularization, see figure 3a for 221 
a summary of the results. As expected from the OEF results, ML estimates of CMRO2 also had 222 
significantly reduced error and bias compared to the rNLS implementation. The proportional bias for 223 
the ML implementation was 0.977 compared to a minimum bias of 0.913 for the rNLS method. The 224 
bisquare RMS error in CMRO2 estimates for the ML implementation was 20.3 μmol/100g/min (22.6 225 
for an individual MLP network) whereas the error for rNLS estimates ranged from 29.6 to 52.4 226 
μmol/100g/min depending on the level of bias (with greater bias coinciding with reduced error), see 227 
figure 3b.  228 
Training of the MLP with reduced feature vectors (excluding the BOLD data) or limited respiratory 229 
stimuli (excluding either CO2 or O2 modulation) highlights the importance of each signal and 230 
stimulus in estimate the rate of oxygen consumption. As expected, removing the BOLD signal 231 
resulted in a significant reduction in the network’s ability to estimate CMRO2 (validation R2 reduced 232 
from 0.923 for the full model to 0.58). In this instance there should be no information relating to OEF 233 
in the feature vector and so the inference is based solely on the correlation between baseline flow and 234 
CMRO2 in the simulated data. Adding the BOLD data back in but with only an O2 stimulus does 235 
little to improve the performance of the network (R2 = 0.63). This is not unexpected as the hyperoxic 236 
BOLD signal is largely related to venous blood volume (Blockley et al., 2013) with little influence 237 
from OEF. Perhaps unexpectedly, including the CO2 stimulus but not the O2 stimulus significantly 238 
improves the ability of the network to infer resting CMRO2 (R2 = 0.71). While this is still 239 
significantly worse than the full model, it suggests that some quantitative metabolic information may 240 
be extracted from hypercapnic calibration studies that are normally employed to estimate relative 241 
changes in CMRO2 (Hoge, 2012). Additionally, such results suggest that the simulation framework 242 
could be utilized to optimize data acquisition by designing respiratory stimuli that maximize the 243 
performance of the ML implementation, and that such respiratory paradigms may be different 244 
compared to those for standard analysis methods (which are unable to infer resting CMRO2 245 
information from a hypercapnic calibration experiment). 246 
5.2 In-vivo 247 
Due to the limited availability and technical challenges associated with acquiring 15-oxygen PET 248 
data for CMRO2 mapping (the gold standard approach) it is difficult to directly validate the in-vivo 249 
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results obtained in this study. However, a number of fundamental relationships between resting 250 
physiological parameters have consistently been observed across groups of healthy individuals. Here 251 
we compare these observed relationships against the acquired data to infer the relative error and bias 252 
for each analysis method. One of the most frequently reported relationships in the healthy human 253 
brain is that resting blood flow is linearly correlated with resting oxygen metabolism (Coles et al., 254 
2006; Lebrun-Grandie et al., 1983; Leenders et al., 1990; Powers et al., 2011; Scheinberg and Stead, 255 
1949). Additionally, PET data suggests that the OEF should be approximately uniform across the 256 
cerebral grey matter e.g. (Hyder et al., 2016). Thus, we can use the coefficient of variation (COV) of 257 
grey matter OEF estimates as an indicator of parameter error, and examine the variation in the slope 258 
of the CBF-CMRO2 relationship to infer the proportional bias or sensitivity to physiological variation 259 
of CMRO2 estimates.  260 
As in the simulation experiments we investigated the in-vivo analysis for varying levels of 261 
regularization in the rNLS analysis and compare this to the ML results. Figure 4b plots the COV in 262 
OEF estimates for increasing levels of regularization against the slope of the CBF-CMRO2 regression 263 
(normalized by the slope of the ML estimate). As predicted by the simulations, the slopes of the ML 264 
estimates and the rNLS estimates are similar when little regularization is applied, with the slope of 265 
the rNLS estimates slightly reduced compared to the ML approach. As more regularization is applied 266 
the COV of OEF estimates is reduced and the slope between CBF and CMRO2 decreases, clearly 267 
demonstrating the trade-off between variance and bias. Again, as predicted by the simulations, the 268 
COV in ML estimates is significantly less than COV in rNLS estimates for a similar CBF-CMRO2 269 
slope.  270 
To investigate the bias in OEF estimates we take advantage of another physiological relationship 271 
reported in the literature; cerebral oxygen extraction is inversely related to [Hb] (Ibaraki et al., 2010) 272 
and the closely related parameter Hct (Morris et al., 2018). Taking the same approach as before we 273 
observe in-vivo results that closely match predictions from the simulation, see figure 4a.  As in the 274 
simulations, the slope in the [Hb]-OEF relationship is similar between the ML method and rNLS 275 
approach for a moderate amount of regularization. However, the slope is substantially increased 276 
when using minimal regularization, and reduced when applying strong regularization.  277 
Figure 5 shows scatter plots of the grey matter CBF-CMRO2 and [Hb]-OEF relationships observed 278 
with the ML and rNLS methods across the 30 healthy volunteers studied. The rNLS results are 279 
shown for a single level of regularization, where the slope of the [Hb]-OEF relationship most closely 280 
matches that of the ML analysis (see figure 4). The coefficient of determination is greater for the ML 281 
approach for each relationship, with R2 values of 0.56 and 0.35 for the CBF-CMRO2 and [Hb]-OEF 282 
relationships, compared to 0.34 and 0.14 for the rNLS approach (p<0.05 for all correlations).  283 
Table 3 reports the results of a bivariate analysis of [Hb] against OEF and CBF for both analysis 284 
methods. The slopes of the relationship between OEF and [Hb] are similar to that reported in healthy 285 
subjects by (Ibaraki et al., 2010), -1.75 Hb (g/dL). As per Ibaraki et al. the relationship between CBF 286 
and OEF did not reach significance (p=0.44) for the ML approach, however a significant negative 287 
correlation was observed in the rNLS analysis (p=0.005). A univariate analysis of CMRO2,0 against 288 
CBF0 is consistent with that observed in healthy controls by (Powers et al., 2011) (β1 = 0.2) for both 289 
analysis methods, β1 = 0.32 (p<0.001) and β1 = 0.24 (p<0.001) for the ML and rNLS approaches 290 
respectively. 291 
Figure 6 shows a comparison between CBF0, OEF0 and CMRO2,0 parameter maps calculated with the 292 
ML method (single MLP network and ensemble of 40 networks) and the rNLS method. The image 293 
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shows 7 slices from a single subject, which have been interpolated for display using cubic b-spline 294 
interpolation (Ruijters and Thevenaz, 2012) using FSLeyes (10.5281/zenodo.1470761). As expected 295 
OEF0 is not well estimated in the white matter, due to the T1 decay of the arterial spin labeling signal 296 
and the longer arrival time of white matter blood. Across grey matter containing voxels maps of 297 
OEF0 calculated with the ML methods are more uniform than those calculated with the rNLS 298 
approach, with the ensemble approach visibly outperforming the singe network MLP estimates. 299 
These observations are consistent with the results of the simulations and the grey matter COV 300 
observed for in-vivo OEF0 estimates. However, it is also apparent from the images that each method 301 
demonstrates sensitivity to regional susceptibility effects. For example, in the pre-frontal cortex and 302 
inferior temporal lobes the images show greater variability in OEF0 estimates, with regions of both 303 
over and under-estimation apparent. This instability is likely due to reduced BOLD SNR in these 304 
locations and alteration of the susceptibility of air in and around the nasal cavity and paranasal 305 
sinuses due to modulation of the inspired oxygen content during data acquisition. It is clear that the 306 
ML estimates, in particular those made from the ensemble of MLPs, are more robust to such regional 307 
susceptibility effects.  308 
The in-vivo analysis also highlights the improvement in computational efficiency of the proposed 309 
method. The rNLS approach took approximately 20 minutes to analyze a complete dataset on a 310 
standard laptop (2.8 Ghz Intel Core i7, 16GB memory), while the ML approach was able to complete 311 
the same analysis in approximately 10 to 20 seconds (depending on the number of networks in the 312 
ensemble of MLP regressors).   313 
6 Discussion and Conclusions 314 
Instability in parameter estimates made using noisy in-vivo data may be reduced by incorporating 315 
prior knowledge of physiological parameters, e.g. (Chappell et al., 2010; Frau-Pascual et al., 2014; 316 
Germuska et al., 2016; Mesejo et al., 2015). Previous investigation of such methods (Germuska et al., 317 
2016) suggests that they are an effective means to increase the robustness of CMRO2 estimates made 318 
with dc-fMRI. However, these methods are computationally expensive and must necessarily make a 319 
trade off between parameter uncertainty and parameter sensitivity. Thus, they are not well suited to 320 
high throughput or rapid data analysis and care must be taken when using such methods not to 321 
unduly bias parameter estimates towards the priors. In the work presented here we take a different 322 
approach by training a machine learning implementation that is robust to input noise. Given an 323 
appropriately selected (or generated) training dataset, a well-implemented solution will be unbiased, 324 
robust, and have a low computational overhead.  325 
Computer modeling suggests that the proposed method outperforms previous analysis methods both 326 
in terms of uncertainty and bias. In-vivo data supports the predicted improvement in uncertainty with 327 
a significant reduction in the COV of grey matter OEF0 estimates when compared to a regularized 328 
non-linear least squares fitting of the data. Additionally, agreement was found between the predicted 329 
behaviors of each method and their associated biases when compared to reported physiological 330 
relationships. Qualitatively, the in-vivo parameter maps suggest that the ML approach, especially 331 
when paired with an ensemble implementation, is more robust to physiological noise; producing 332 
physiologically plausible parameter estimates in challenging brain regions, e.g. near the frontal 333 
sinuses. Such physiological noise was not modeled in the training data so it is perhaps unexpected 334 
that the ML method is robust to these noise sources. However, it is plausible that the discriminative 335 
features identified from the frequency-domain representation of the data during training are less 336 
sensitive to these regional susceptibility changes than a traditional time-domain fit of the data. It is 337 
possible that this aspect of the ML approach could be enhanced by extending the training data to 338 
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include such regional susceptibility changes, either on their own or in combination with a spatially 339 
informed approach to data fitting.  340 
The use of an ensemble of MLP networks reduced parameter uncertainty in simulation and reduced 341 
the coefficient of variation in grey matter OEF0 estimates in-vivo, demonstrating its utility in this 342 
application. However, it is anticipated that enforcing network diversity during training could make 343 
further improvements in performance. As it is has previously been demonstrated that, in the presence 344 
of noise, the performance of an ensemble of networks can always be improved by explicitly 345 
encouraging diversity during training (Reeve and Brown, 2018). 346 
The machine learning implementation presented here employs a combination of proven signal 347 
processing (time-frequency transformation) and machine learning methods (decision trees and fully 348 
connected artificial neural networks) that have been shown to select appropriate features for learning 349 
and are robust to input noise. The proposed analysis pipeline demonstrates an improvement in both 350 
the accuracy and precision in parameter estimates compared to published methods, and is appropriate 351 
for the study of both healthy volunteers and in clinical investigations. However, there are still many 352 
avenues that could be explored both in terms of signal processing and machine-learning. For example 353 
time domain data could be converted to 2D time-frequency representations such as a spectrogram, or 354 
into spectrogram-like representations using wavelet transforms (for increased time resolution). This 355 
type of pre-processing would open the door to the application of 2D convolution neural networks 356 
(CNN) that have been so successfully applied in the domain of image processing. It is possible that 357 
the application of such approaches could further improve the performance of machine learning when 358 
analyzing dc-fMRI data. However, a thorough investigation of all available machine learning 359 
methods and associated pre-conditioning of the data is beyond the scope of the current study, which 360 
focuses instead on the realization of a practical solution by combining well-proven techniques for the 361 
analysis of signal data.  362 
All in-vivo analysis in this manuscript is performed in the absence of spatial smoothing, which is 363 
often employed to improve statistical estimates made from fMRI data (Friston et al., 1995). We chose 364 
not to employ spatial smoothing in this analysis for two principle reasons: first any such spatial 365 
filtering implies a prior assumption regarding the spatial extent of any variation (Rosenfeld and Kak, 366 
1982), and can thus lead to unwanted loss of sensitivity to physiological variation; second we did not 367 
want to increase the potential contamination of grey matter voxels with non-tissue signals, such as 368 
CSF or macrovessels (both of which are not included in the underlying signal model). The current 369 
study does not make any direct comparison between smoothed and unsmoothed analysis pipelines, 370 
however the presented method clearly avoids any possible smoothing artefacts that might otherwise 371 
bias the analysis. 372 
A limitation of the proposed method is the need to train new regressors for a given gas paradigm and 373 
set of acquisition parameters, e.g. arterial spin labeling tagging duration, repetition time and duration 374 
of the acquisition. In addition, there is a requirement that the in-vivo gas manipulation does not 375 
deviate significantly from the range of simulated designs. While it is a relatively straightforward 376 
process to retrain the regressors with a new set of parameters, to match the local acquisition protocol, 377 
the scope of the method could be increased if individualized gas traces could be incorporated into the 378 
training data; allowing a single pre-trained implementation to be applied across studies. 379 
The simulations and in-vivo results suggest that the proposed analysis method could significantly 380 
increase the utility of dc-fMRI, reducing the number of participants needed to detect a group 381 
difference in oxygen metabolism or oxygen extraction fraction and offering more physiological 382 
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interpretability of metabolic differences or alteration due to a stimulus. In addition, the significant 383 
reduction in processing time and the improved robustness of the individual parameter maps reduces 384 
two of the hurdles restricting clinical implementation of such techniques. 385 
 386 
Tables  387 
OEF CBF 
(ml/100g/min) 
[Hb] 
(g/dL) 
Mean capillary transit 
time  
(CBVcap / CBF, seconds) 
PminO2 
(mmHg) 
Cerebral Vascular 
Reactivity 
(% CBF / mmHg CO2) 
K 
0.05 – 
0.75 
1 – 250 10-18 0.25 – 4.0 0 - 30 1 - 7 0.01 – 
0.25 
Table 1. Range of physiological parameters used in the dc-fMRI data simulations for training of the 388 
machine learning regressors. 389 
Variable / 
abbreviation 
Expression (units) 
OEF 
CMRO2 
CBF 
φ 
[Hb] 
CaO2 
PaO2 
SaO2 
SvO2 
α 
β 
BOLD 
ASL 
M0blood 
PLD 
M 
K 
D 
CBVcap 
PminO2 
Oxygen Extraction Fraction (dimensionless) 
Cerebral Metabolic Rate of Oxygen consumption (μmol/100g/min) 
Cerebral Blood Flow (ml/100g/min)  
Oxygen binding capacity of hemoglobin (1.34 ml/g) 
Hemoglobin concentration (g/dL) 
Arterial oxygen content (ml/ml) 
Arterial oxygen tension (mmHg) 
Arterial oxygen saturation (dimensionless) 
Venous oxygen saturation (dimensionless) 
Grubb exponent 
Venous morphology / deoxy-hemoglobin - BOLD exponent 
Blood Oxygenation Level Dependent signal 
Arterial Spin Labeling 
Arterial blood MRI signal equilibrium magnetization (dimensionless) 
ASL post-label delay time (1.0 – 3.0 seconds) 
Maximum possible BOLD signal (BOLD calibration parameter) 
BOLD scaling factor = M / ([Hb] x (1-SvO2))β   
Effective oxygen diffusivity of the capillary network (μmol/100g/mmHg/min) 
Capillary blood volume (ml/100g) 
Minimum oxygen partial pressure at the mitochondria (mmHg) 
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h 
κ 
Hill coefficient (2.8) 
Effective permeability of capillary endothelium and brain tissue 
(μmol/mmHg/ml/min) 
Table 2. Summary of model parameters and abbreviation used in the dc-fMRI data simulations and 390 
their definitions. 391 
Predictor ML β1 (p value) rNLS β1 (p value) 
OEF -1.42 (0.001) -2.23 (0.001) 
CBF -0.07 (0.44) -0.37 (0.005) 
Intercept 61.95 (<0.001) 89.48 (<0.001) 
Table 3. Results of a bivariate regression of [Hb] against CBF0 and OEF0 grey mater estimates for 30 392 
healthy volunteers analyzed with the ML (ensemble of MLPs) and rNLS fitting methods. 393 
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